Compare IRTC & ACMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | ACMR |
|---|---|---|
| Founded | 2006 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.2B |
| IPO Year | 2016 | 2017 |
| Metric | IRTC | ACMR |
|---|---|---|
| Price | $121.66 | $54.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 1 |
| Target Price | ★ $197.92 | $50.00 |
| AVG Volume (30 Days) | 381.0K | ★ 927.6K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.71 | N/A |
| EPS | N/A | ★ 1.37 |
| Revenue | ★ $747,138,000.00 | $74,643,000.00 |
| Revenue This Year | $19.60 | $29.37 |
| Revenue Next Year | $15.94 | $23.16 |
| P/E Ratio | ★ N/A | $37.24 |
| Revenue Growth | 26.24 | ★ 104.47 |
| 52 Week Low | $103.16 | $17.32 |
| 52 Week High | $210.01 | $71.65 |
| Indicator | IRTC | ACMR |
|---|---|---|
| Relative Strength Index (RSI) | 48.55 | 63.78 |
| Support Level | $119.48 | $49.37 |
| Resistance Level | $124.40 | $54.83 |
| Average True Range (ATR) | 4.54 | 2.40 |
| MACD | 1.02 | 1.27 |
| Stochastic Oscillator | 55.42 | 98.67 |
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
ACM Research Inc supplies capital equipment developed for the semiconductor industry. The company focuses on developing differentiated process solutions that enable effective particle removal, uniform material deposition, and reliable process control for the fabricators of integrated circuits. Its product offerings include wet-cleaning, plating, furnace, PECVD, track, and other front-end processing equipment. Additionally, it develops, manufactures, and sells a range of packaging equipment to wafer assembly and packaging customers. Geographically, the company generates maximum revenue from its customers in Mainland China, and the rest from other regions.